Home > News > WallStreet Research Initiates Coverage of BioSante Pharmaceuticals
March 26th, 2004
WallStreet Research Initiates Coverage of BioSante Pharmaceuticals
WallStreet Research led by Alan Stone, Managing Director of Alan Stone & Company, LLC, announced today that it has released an analyst research report initiating coverage of BioSante Pharmaceuticals, Inc. The complete analyst research report on BioSante Pharmaceuticals, Inc., together with the risks associated therewith and additional information about WallStreet Research is available online.
Aspen Aerogels, Inc. Schedules Fourth Quarter and Fiscal 2014 Earnings Release and Conference Call for February 26, 2015 February 11th, 2015
Arrowhead to Report Fiscal 2015 First Quarter Financial Results February 2nd, 2015
Graphenea sales more than double in 2014 January 29th, 2015
Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 2, 2015 January 7th, 2015